Nombre del producto:N-(3-chloroquinoxalin-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-6-sulfonamide

IUPAC Name:N-(3-chloroquinoxalin-2-yl)-2,3-dihydro-1,4-benzodioxine-6-sulfonamide

CAS:522628-94-0
Fórmula molecular:C16H12ClN3O4S
Pureza:95%+
Número de catálogo:CM1050312
Peso molecular:377.8

Unidad de embalaje Stock disponible Precio($) Cantidad
CM1050312-1g in stock ưũƀ
CM1050312-5g in stock ȺǜƦǜ
CM1050312-10g in stock ȺȬƦƀ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :522628-94-0
Fórmula molecular:C16H12ClN3O4S
Punto de fusión:-
Código de sonrisas:ClC1=C(NS(=O)(=O)C2=CC=C3OCCOC3=C2)N=C2C=CC=CC2=N1
Densidad:
Número de catálogo:CM1050312
Peso molecular:377.8
Punto de ebullición:555.6±60.0 °C at 760 mmHg
Nº Mdl:
Almacenamiento:

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.